trending Market Intelligence /marketintelligence/en/news-insights/trending/hms0ctnf7j8cdsmxw7q99w2 content esgSubNav
In This List

China Resources Pharmaceutical director resigns

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective

Blog

Corporate Credit Risk Trends in Developing Markets: A Probability of Default Perspective


China Resources Pharmaceutical director resigns

Wang Jing resigned as a nonexecutive director of China Resources Pharmaceutical Group Ltd. due to other work commitments.

Wang is the CFO of Beijing State-Owned Capital Operations and Management Center, or BSCOMC, an investment and asset management firm focused on China. BSCOMC is also an investor in China Resources, according to S&P Capital IQ data.

Concurrently, China Resources appointed Wang Shouye and Lu Ruizhi to its board as nonexecutive directors.

Lu is BSCOMC's general manager of the investment management second division.

Hong Kong-based China Resources is an investment holding company involved in the development and distribution of pharmaceutical and healthcare products in China and Hong Kong.